MiMedx Group, Inc.
NASDAQ:MDXG
9.1 (USD) • At close December 20, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 321.477 | 267.841 | 258.615 | 248.234 | 299.255 | 359.111 | 321.139 | 245.015 | 187.296 | 118.223 | 59.181 | 27.054 | 7.76 | 0.789 | 0 | 0 | 0 | 0 |
| Cost of Revenue
| 54.634 | 48.316 | 43.283 | 39.33 | 43.081 | 36.386 | 35.219 | 32.407 | 20.202 | 12.665 | 9.328 | 5.188 | 3.155 | 1.72 | 0 | 0 | 0 | 0 |
| Gross Profit
| 266.843 | 219.525 | 215.332 | 208.904 | 256.174 | 322.725 | 285.92 | 212.608 | 167.094 | 105.558 | 49.853 | 21.865 | 4.606 | -0.931 | 0 | 0 | 0 | 0 |
| Gross Profit Ratio
| 0.83 | 0.82 | 0.833 | 0.842 | 0.856 | 0.899 | 0.89 | 0.868 | 0.892 | 0.893 | 0.842 | 0.808 | 0.594 | -1.18 | 0 | 0 | 0 | 0 |
| Reseach & Development Expenses
| 12.665 | 22.829 | 17.344 | 11.715 | 11.14 | 15.765 | 17.9 | 12.038 | 8.413 | 7.05 | 4.843 | 2.885 | 2.603 | 2.753 | 4.023 | 2.013 | 0 | 0 |
| General & Administrative Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 7.956 | 0 | 0 | 0 |
| Selling & Marketing Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| SG&A
| 211.124 | 208.789 | 198.359 | 181.022 | 198.205 | 258.528 | 220.119 | 179.997 | 133.384 | 90.48 | 46.226 | 20.971 | 11.764 | 6.848 | 7.956 | 8.659 | 0.037 | 0.016 |
| Other Expenses
| 5.938 | 12.878 | 4.611 | 60.538 | 67.543 | 0.527 | -0.087 | 2.127 | 0.933 | 0.928 | 1.054 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Expenses
| 229.727 | 244.496 | 220.314 | 253.275 | 276.888 | 326.649 | 239.697 | 194.162 | 142.73 | 98.458 | 52.123 | 23.855 | 14.367 | 9.601 | 11.979 | 10.672 | 0.037 | 0.016 |
| Operating Income
| 37.116 | -24.971 | -5.005 | -44.371 | -20.714 | -3.924 | 46.223 | 18.446 | 24.364 | 7.1 | -2.639 | -5.355 | -9.761 | -10.533 | -11.979 | -17.849 | -0.037 | -0.016 |
| Operating Income Ratio
| 0.115 | -0.093 | -0.019 | -0.179 | -0.069 | -0.011 | 0.144 | 0.075 | 0.13 | 0.06 | -0.045 | -0.198 | -1.258 | -13.352 | 0 | 0 | 0 | 0 |
| Total Other Income Expenses Net
| -6.483 | -5.02 | -2.987 | -16.145 | -4.425 | 0.527 | -1.135 | -0.339 | -0.086 | -0.048 | -1.373 | -2.307 | -0.433 | -0.887 | 0.06 | -5.393 | -0.002 | -0.635 |
| Income Before Tax
| 30.633 | -29.991 | -10.038 | -61.543 | -25.585 | -3.397 | 45.088 | 18.107 | 24.278 | 7.052 | -4.012 | -7.662 | -10.194 | -11.42 | -11.919 | -17.371 | -0.039 | -0.017 |
| Income Before Tax Ratio
| 0.095 | -0.112 | -0.039 | -0.248 | -0.085 | -0.009 | 0.14 | 0.074 | 0.13 | 0.06 | -0.068 | -0.283 | -1.314 | -14.476 | 0 | 0 | 0 | 0 |
| Income Tax Expense
| -36.806 | 0.206 | 0.247 | -12.259 | -0.005 | 26.582 | -19.639 | 6.133 | -5.168 | 0.832 | 0.1 | 2.307 | 0.433 | 0.887 | -0.06 | -0.478 | 0 | 0 |
| Net Income
| 67.439 | -30.197 | -10.285 | -49.284 | -25.58 | -29.979 | 64.727 | 11.974 | 29.446 | 6.22 | -4.112 | -7.662 | -10.194 | -11.42 | -11.919 | -17.371 | -0.039 | -0.017 |
| Net Income Ratio
| 0.21 | -0.113 | -0.04 | -0.199 | -0.085 | -0.083 | 0.202 | 0.049 | 0.157 | 0.053 | -0.069 | -0.283 | -1.314 | -14.476 | 0 | 0 | 0 | 0 |
| EPS
| 0.48 | -0.27 | -0.093 | -0.46 | -0.24 | -0.28 | 0.61 | 0.004 | 0.28 | 0.06 | -0.043 | -0.094 | -0.14 | -0.19 | -0.32 | -3 | -0.005 | -0.003 |
| EPS Diluted
| 0.38 | -0.27 | -0.093 | -0.46 | -0.24 | -0.28 | 0.56 | 0.004 | 0.26 | 0.05 | -0.043 | -0.094 | -0.14 | -0.19 | -0.32 | -3 | -0.005 | -0.003 |
| EBITDA
| 40.517 | -10.685 | -1.891 | -45.764 | -12.345 | 2.992 | 53.036 | 23.906 | 27.096 | 9.225 | -0.947 | -3.51 | -7.979 | -9.708 | -10.887 | -10.827 | -0.037 | -0.016 |
| EBITDA Ratio
| 0.126 | -0.078 | 0.001 | -0.151 | -0.042 | 0.008 | 0.165 | 0.098 | 0.145 | 0.078 | -0.01 | -0.074 | -1.028 | -12.306 | 0 | 0 | 0 | 0 |